Alnylam Extends Research Deal with UBC, AlCana
April 07, 2011
Alnylam Extends Research Deal with UBC, AlCana
Under the terms of the research alliance, which was forged in 2009, Alnylam has the exclusive rights to all new inventions in the RNAi field, as well as rights to sublicense any resulting intellectual property to Alnylam's current and future partners.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alnylam, Tekmira Form New RNAi Drug-Delivery Collaboration
August 6, 2009 / Gene Silencing News - AlCana Denies Breaking Non-Compete Pact as Tekmira Decries Deception in Ongoing Lawsuit
August 18, 2011 / Gene Silencing News - Tekmira Amends Alnylam Lawsuit to Include AlCana Technologies
June 9, 2011 / Gene Silencing News - Alnylam to Release Phase II ATTR Data, Launch Expansion Trial in Coming Months
May 9, 2013 / Gene Silencing News - Tekmira Provides Pipeline Update, Eyes Agricultural Market
February 14, 2013 / Gene Silencing News